Ulka Vaishampayan

Professor

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Joseph Kim

Yale University Yale Cancer Center

UNITED STATES

View details

Wei Chen

Professor

Wayne State University

UNITED STATES

View details

Nancy Davis

Associate Professor of Medicine & Urology

Vanderbilt University Medical Center

UNITED STATES

View details

Menggang Yu

University of Wisconsin-Madison

UNITED STATES

View details

Leonard Appleman

Associate Professor

University of Pittsburgh

UNITED STATES

View details

Yu Shyr

Professor and Chair

Vanderbilt University Medical Center

UNITED STATES

View details

Yousef Zakharia

The University of Iowa

UNITED STATES

View details

Russell K. Pachynski

Washington University School of Medicine

UNITED STATES

View details

Amy Schienschang

University of Virginia

UNITED STATES

View details

Susan Moran

Hospital of the University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ulka Vaishampayan

Research Interests

Explore related searches

Contact this professor

Articles (10)

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations

Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer

A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience

Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study

Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer

Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma

Current State of Systemic Therapies for Advanced Renal Cell Carcinoma

Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results

Collaborators (10)

Joseph Kim

Wei Chen

Nancy Davis

Menggang Yu

Leonard Appleman

Yu Shyr

Yousef Zakharia

Russell K. Pachynski

Amy Schienschang

Susan Moran

Make your next move.